These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13847033)

  • 1. Serotonin degradation by ceruloplasmin and its inhibition by isoniazid and iproniazid.
    ZARAFONETIS CJ; KALAS JP
    Am J Med Sci; 1960 Feb; 239():203-6. PubMed ID: 13847033
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution to the study of serum oxidases and ceruloplasmin in experimental psychiatry].
    NAKAJIMA H
    Encephale; 1959; 48():313-52. PubMed ID: 14425888
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of intra-articular serotonin and competitive amines on connective tissue proliferation in rabbit joints.
    SMYTH CJ; GUM OB; HAMILTON PK
    J Lab Clin Med; 1962 Sep; 60():492-503. PubMed ID: 13914529
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebral circulatory and cochleovestibular manifestations of isoniazid and iproniazid].
    RISER M; GAYRAL L; GERAUD J; COLL J; TURNIN J
    Rev Neurol (Paris); 1959 Nov; 101():610-8. PubMed ID: 14437548
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of certain compounds on in vitro degradation of serotonin by ceruloplasmin.
    ZARAFONETIS CJ; KALAS JP
    Proc Soc Exp Biol Med; 1960 Dec; 105():560-3. PubMed ID: 13787921
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxidation of serotonin in the presence of ceruloplasmin.
    PORTER CC; TITUS DC; SANDERS BE; SMITH EV
    Science; 1957 Nov; 126(3281):1014-5. PubMed ID: 13486052
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of 5-hydroxytryptamine release from blood platelets by N2-isopropyl isonicotinic acid hydrazide.
    PAASONEN MK; PLETSCHER A
    Experientia; 1960 Jan; 16():30-1. PubMed ID: 14429629
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxidation of reduced phosphopyridine nucleotides by p-phenylenediamines, catecholamines and serotonin in the presence of ceruloplasmin.
    WALAAS E; WALAAS O
    Arch Biochem Biophys; 1961 Oct; 95():151-62. PubMed ID: 14004499
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of 5-hydoxytryptamine in platelet-free plasma of rabbits.
    Paasonen MK; Airaksinen MM
    Ann Med Exp Biol Fenn; 1965; 43(4):231-5. PubMed ID: 4379168
    [No Abstract]   [Full Text] [Related]  

  • 10. The heterogeneity of ceruloplasmin: isolation and characterization of 2 cuproproteins from human serum.
    RICHTERICH R; TEMPERLI A; AEBI H
    Biochim Biophys Acta; 1962 Jan; 56():240-51. PubMed ID: 14492064
    [No Abstract]   [Full Text] [Related]  

  • 11. An improved colorimetric enzymatic assay of ceruloplasmin.
    RAVIN HA
    J Lab Clin Med; 1961 Jul; 58():161-8. PubMed ID: 13739892
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors influencing serum copper and ceruloplasmin oxidative activity in the rat.
    MEYER BJ; MEYER AC; HORWITT MK
    Am J Physiol; 1958 Sep; 194(3):581-4. PubMed ID: 13571430
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro effect of nonindole compounds on oxidative activity of ceruloplasmin.
    HANSON KM; AUSTIN DC; APRISON MH
    J Appl Physiol; 1959 May; 14(3):363-7. PubMed ID: 13654164
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ceruloplasmin in psychiatric research].
    SCHOU M
    Nord Med; 1960 Feb; 63():168-71. PubMed ID: 14443507
    [No Abstract]   [Full Text] [Related]  

  • 15. Continued studies on the effect of ceruloplasmin administration in schizophrenic patients.
    MARTENS S; VALLBO S; KYHLBERG KO; JONSSON CO
    J Neuropsychiatr; 1961 Jun; 2():238-45. PubMed ID: 13767284
    [No Abstract]   [Full Text] [Related]  

  • 16. Ceruloplasmin reaction in mental disorders.
    AIVAZIAN GH; GRIFFITH JD
    AMA Arch Gen Psychiatry; 1960 Jan; 2():7-11. PubMed ID: 13792210
    [No Abstract]   [Full Text] [Related]  

  • 17. Ceruloplasmin activity and copper levels in the serum of children with schizophrenia.
    BAKWIN RM
    J Am Med Womens Assoc; 1961 Jul; 16():522-3. PubMed ID: 13686173
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of a relationship between ceruloplasmin and nonspecific hyaluronidase inhibitor.
    RANTZ LA; RANDALL E
    AMA Arch Intern Med; 1958 Feb; 101(2):252-3. PubMed ID: 13497322
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceruloplasmin in early childhood.
    POJEROVA A; TOVAREK J
    Acta Paediatr (Stockh); 1960 Mar; 49():113-20. PubMed ID: 14433697
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of blood ceruloplasmin in schizophrenia and other disorders.
    ABOOD LG; GIBBS FA; GIBBS E
    AMA Arch Neurol Psychiatry; 1957 Jun; 77(6):643-5. PubMed ID: 13423938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.